Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Hong Kong · Delayed Price · Currency is HKD 3.360
-0.080 (-2.33%)
Jul 31, 2026, 4:08 PM HKT
HKG:1066 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 13,389 | 13,389 | 13,087 | 13,229 | 13,747 | 13,209 |
Revenue Growth | 2.24% | 2.31% | -1.08% | -3.77% | 4.08% | 13.65% |
Gross Profit Gross Profit Growth | 6,327 | 6,327 | 6,536 | 6,611 | 7,293 | 7,336 |
Operating Income Operating Income Growth | 1,846 | 1,846 | 2,274 | 2,181 | 3,043 | 3,003 |
Net Income Net Income Growth | 1,612 | 1,612 | 2,067 | 2,002 | 2,764 | 2,276 |
Earnings Per Share EPS Growth | 0.35 | 0.35 | 0.45 | 0.44 | 0.61 | 0.50 |
EPS Growth | -18.65% | -22.22% | 2.27% | -27.92% | 21.18% | 9.51% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Orthopaedic Products Orthopaedic Products Growth | 1,523 | 1,523 | 1,439 | 1,271 | 2,038 | 2,127 |
Interventional Products Interventional Products Growth | 2,006 | 2,006 | 1,980 | 1,931 | 1,726 | 1,544 |
Pharma Packaging Products Pharma Packaging Products Growth | 2,288 | 2,288 | 2,279 | 2,024 | 2,105 | 2,040 |
Blood Management Products Blood Management Products Growth | 995.11 | 995.11 | 876.78 | 1,042 | 1,098 | 976.86 |
Eliminations Eliminations Growth | -94.07 | -94.07 | -88.05 | -45.8 | -50.8 | -0.11 |
Medical Device Products Medical Device Products Growth | 6,671 | 6,671 | 6,600 | 7,007 | 6,831 | 6,521 |
Total Total Growth | 13,389 | 13,389 | 13,087 | 13,229 | 13,747 | 13,209 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 9,453 | 9,453 | 8,322 | 7,333 | 7,486 | 7,133 |
Total Debt Total Debt Growth | 5,103 | 5,103 | 4,193 | 4,169 | 4,491 | 4,138 |
Net Cash (Debt) Net Cash Growth | 4,349 | 4,349 | 4,129 | 3,164 | 2,995 | 2,996 |
Net Cash Growth | 5.06% | 5.34% | 30.49% | 5.65% | -0.03% | 65.65% |
Net Cash Per Share Net Cash Per Share Growth | 0.96 | 0.96 | 0.91 | 0.70 | 0.66 | 0.66 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,551 | 2,551 | 2,790 | 2,799 | 2,295 | 3,087 |
Capital Expenditures CapEx Growth | -784.72 | -784.72 | -598.05 | -647.58 | -1,070 | -1,120 |
Free Cash Flow Free Cash Flow Growth | 1,766 | 1,766 | 2,192 | 2,151 | 1,225 | 1,967 |
Free Cash Flow Growth | -13.89% | -19.44% | 1.91% | 75.63% | -37.72% | 4.56% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 47.26% | 47.26% | 49.94% | 49.97% | 53.05% | 55.54% |
Operating Margin | 13.79% | 13.79% | 17.37% | 16.49% | 22.13% | 22.73% |
Pretax Margin | 15.17% | 15.17% | 19.51% | 17.91% | 24.63% | 21.79% |
Profit Margin | 12.04% | 12.04% | 15.79% | 15.13% | 20.11% | 17.23% |
FCF Margin | 13.19% | 13.19% | 16.75% | 16.26% | 8.91% | 14.89% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.182 | 0.157 | 0.215 | 0.168 | 0.165 | 0.142 |
Dividend Per Share Growth | -25.67% | -27.16% | 28.44% | 1.64% | 16.20% | 9.23% |
Dividend Yield | 5.42% | 3.55% | 5.31% | 2.70% | 1.65% | 2.07% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.63 | 12.70 | 9.56 | 15.77 | 18.75 | 15.75 |
Forward PE | 8.19 | 9.05 | 8.82 | 11.02 | 17.48 | 12.63 |
P/FCF Ratio | 7.72 | 11.60 | 9.01 | 14.68 | 42.32 | 18.23 |
PS Ratio | 1.02 | 1.53 | 1.51 | 2.39 | 3.77 | 2.71 |